Related Experiment Video

Updated: Apr 23, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Slit/Robo pathway: a promising therapeutic target for cancer

Rishi K Gara1, Sonam Kumari1, Aditya Ganju1

  • 1Department of Pharmaceutical Sciences and Center for Cancer Research, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Drug Discovery Today
|September 24, 2014
PubMed

Insights

The Slit/Robo pathway, involving slit glycoprotein (Slit) and Roundabout receptor (Robo), regulates physiological processes and plays a key role in cancer progression and metastasis. This pathway presents a promising target for novel anticancer drug development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Slit glycoprotein (Slit) and Roundabout receptor (Robo) are critical axon guidance molecules.
  • Emerging evidence highlights their significant roles in tumorigenesis, cancer progression, and metastasis.

Purpose of the Study:

  • To comprehensively review the function of Slit and Robo molecules and their signaling pathways in cancer.
  • To evaluate the Slit/Robo pathway as a potential therapeutic target for cancer treatment.

Main Methods:

  • Literature review of studies on Slit/Robo pathway in cancer.
  • Analysis of the role of Slit/Robo in regulating oncogenic signaling pathways.

Main Results:

  • The Slit/Robo pathway acts as a master regulator for multiple oncogenic signaling cascades.
  • Dysregulation of Slit/Robo signaling is implicated in various aspects of cancer development and spread.

Conclusions:

  • The Slit/Robo pathway is integral to cancer progression and metastasis.
  • Targeting the Slit/Robo pathway offers a promising strategy for developing new anticancer therapies.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K